Fully Integrated SCIEX OS Software Launches at Virtual Product Experience
July 09 2020 - 11:00AM
Business Wire
Built on usability, efficiency and integrity,
SCIEX OS Software Powers Up the latest innovations in mass
spectrometry
SCIEX, a global leader in life science analytical technologies,
introduces the fully integrated SCIEX OS Software, the core engine
running SCIEX innovations. Today, SCIEX OS Software becomes
available on the Echo® MS System and the SCIEX Triple Quad™ 7500
LC-MS/MS System – QTRAP® Ready.
“SCIEX OS Software has made mass spec more accessible.
Instrumentation may be more complicated, but the beauty of SCIEX OS
Software is that it’s straightforward,” says Rachel Rowlinson,
Specialist in Protein Mass Spectrometry at Peak Proteins. “My team
can deconvolute technically complicated data. The software has been
a big driving force for moving efficiency within groups like
ours.”
With an intuitive and user-friendly design, SCIEX OS Software
powers up mass spectrometry for every user. Key features
include:
- Usability – Data analysis becomes
easy with shared tools, automation and reduced manual intervention.
- Auto-detection of sample failures results in
auto-corrective action.
- Review by exception flags means less manual checking of
results.
- Efficiency – Results are optimized
with powerful integration algorithms.
- Peak modeling improves peak finding and integration,
requiring less user input and therefore reduces time for data
review.
- Automated result checking and outlier removal minimizes
the time it takes to establish an approved calibration range.
- Integrity - Intuitive audit
trails ensure full traceability and accountability to achieve
data precision, completeness and consistency across every run, on
every system.
“Software at times is equally if not more important than the
instrument itself. In situations where the amount of samples
analyzed is key, having complex software that bottlenecks the
operation is not ideal,” says Wim Broer, Manager of Science and
Development at Nofalab. “The new SCIEX OS Software, specifically on
the 7500 System has seen significant improvements. The organization
is better and it’s easier to set up methods.”
Dominic Gostick, Vice President of LCMS adds, “The confidence
and enthusiasm customers have voiced for SCIEX OS Software
reinforces our plan to build this platform as our core software
offering. In fact, future integrations with our other systems will
be available later this year. While we continue to innovate, we
recognize the challenges posed by validation and are committed to
supporting our customers through the transition.”
“When we switched to SCIEX OS, we also implemented network
acquisition so that remote access to the data and remote processing
would be possible. With the concurrent licensing model, we could
leverage licenses within our organization in Belgium and across the
ocean with US colleagues. In times of COVID where a lot of people
have to work remotely, it has given us a lot of benefit,” says Marc
De Meulder, Senior Bioanalytical Scientist within the Development
Bioanalysis group of Janssen R&D in Belgium.
To learn more about SCIEX OS Software, visit
www.sciex.com/powerup.
About SCIEX
SCIEX delivers solutions for the precision detection and
quantification of molecules, empowering our customers to protect
and advance the wellness and safety of all. We have led the field
of mass spectrometry for 50 years. From the launch of the first
ever commercially successful triple quadrupole in 1981, we have
developed groundbreaking technologies and solutions that influence
life-changing research and outcomes.
Today, as part of the Danaher (NYSE: DHR) family of global life
science and technology innovators, we continue to pioneer robust
solutions in mass spectrometry and capillary electrophoresis. Our
customers are able to quickly respond to environmental hazards,
better understand biomarkers relevant to disease, improve patient
care in the clinic, bring relevant drugs to market faster and keep
food healthier and safer.
That’s why thousands of life science experts around the world
choose SCIEX to get the answers they can trust to better inform
critical decisions that positively impact lives.
For more information, visit sciex.com.
Let’s connect: Twitter, LinkedIn, Facebook, and Instagram.
Advances in human wellness depend on the power of precise
science.
The SCIEX clinical diagnostic portfolio is For In Vitro
Diagnostic Use. Rx Only. Product(s) not available in all countries.
For information on availability, please contact your local sales
representative or refer to https://sciex.com/diagnostics. All other
products are For Research Use Only. Not for use in Diagnostic
Procedures.
Trademarks and/or registered trademarks mentioned herein,
including associated logos, are the property of AB Sciex Pte. Ltd.
or their respective owners in the United States and/or certain
other countries.
© 2020 DH Tech. Dev. Pte. Ltd. RUO-MKT-12-11918-A.
Echo and Echo MS are trademarks or registered trademarks of
Labcyte, Inc. in the United States and other countries, and are
being used under license.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200709005099/en/
Lulu VanZandt Manager, Brand, Public Relations and Social Media,
SCIEX lulu.vanzandt@sciex.com +1 (508) 383-7163 M: +1 (508)
782-9484
Danaher (NYSE:DHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Danaher (NYSE:DHR)
Historical Stock Chart
From Apr 2023 to Apr 2024